Drug Dosing During Intermittent Hemodialysis and Continuous Renal Replacement Therapy: Special Considerations in Pediatric Patients

Author： Veltri M.A.  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.6, Iss.1, 2004-01, pp. : 45-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic Considerations for Antimicrobial Therapy in Patients Receiving Renal Replacement Therapy

By Pea Federico  

Clinical Pharmacokinetics, Vol. 46, Iss. 12, 2007-01 ,pp. : 997-1038

Adis International

Access to resources Recommend Favorite

Using Imipenem and Cilastatin During Continuous Renal Replacement Therapy

By Cotton Alison   Franklin Bryony   Brett Stephen   Holmes Alison  

Pharmacy World and Science, Vol. 27, Iss. 5, 2005-10 ,pp. : 371-375

Springer Publishing Company

Access to resources Recommend Favorite

Hemodialysis Systems for Intermittent, Semi‐Continuous, and Continuous Therapies in Acute Renal Failure

By  

Hemodialysis International, Vol. 2, Iss. 1, 1998-01 ,pp. : 30-33

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of Uveitis in Pediatric Patients: Special Considerations

By Smith J.R.  

Pediatric Drugs, Vol. 4, Iss. 3, 2002-01 ,pp. : 183-189

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

By Isla Arantxazu  

Clinical Pharmacokinetics, Vol. 47, Iss. 3, 2008-01 ,pp. : 173-180

Adis International

Access to resources Recommend Favorite